Study identifies distinct outcomes and genomic features in NSCLC with class II and III BRAF alterations

Patients with metastatic non-small compartment lung crab (NSCLC) harboring people II and people III BRAF alterations person chiseled clinicopathologic and genomic characteristics, with people III alterations perchance associated with worse prognosis, according to probe presented astatine the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference connected Lung Cancer (WCLC).